Neo Ivy Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Sell |
23,067
-13,179
| -36% | -$644K | 0.36% | 101 |
|
|
2025
Q1 | $1.85M | Buy |
+36,246
| New | +$1.85M | 0.59% | 76 |
|
|
2024
Q3 | – | Sell |
-40,708
| Closed | -$1.25M | – | 372 |
|
|
2024
Q2 | $1.25M | Buy |
+40,708
| New | +$1.25M | 0.24% | 132 |
|
|
2023
Q4 | – | Sell |
-11,800
| Closed | -$264K | – | 426 |
|
|
2023
Q3 | $264K | Buy |
11,800
+11,335
| +2,438% | +$254K | 0.12% | 215 |
|
|
2023
Q2 | $19K | Buy |
+465
| New | +$19K | 0.01% | 268 |
|
|
2022
Q4 | $234K | Buy |
+6,132
| New | +$234K | 0.16% | 215 |
|
|
2022
Q3 | – | Sell |
-2,969
| Closed | -$118K | – | 512 |
|
|
2022
Q2 | $118K | Buy |
+2,969
| New | +$118K | 0.32% | 133 |
|
|
2021
Q4 | – | Sell |
-1,320
| Closed | -$67K | – | 591 |
|
|
2021
Q3 | $67K | Buy |
+1,320
| New | +$67K | 0.08% | 296 |
|
|
2020
Q3 | – | Sell |
-1,320
| Closed | -$67K | – | 587 |
|
|
2020
Q2 | $67K | Buy |
1,320
+292
| +28% | +$14.8K | 0.08% | 296 |
|
|
2020
Q1 | $46K | Sell |
1,028
-585
| -36% | -$26.2K | 0.07% | 323 |
|
|
2019
Q4 | $77K | Buy |
+1,613
| New | +$77K | 0.09% | 195 |
|
|
2019
Q3 | – | Sell |
-25,114
| Closed | -$1.13M | – | 373 |
|
|
2019
Q2 | $1.13M | Buy |
+25,114
| New | +$1.13M | 0.64% | 61 |
|